Naratriptan

CHEMBL1278 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

335.5 g/mol

LogP

2.0

Phase

4

This medication is used to treat migraine headaches with or without aura by narrowing blood vessels in the brain and blocking pain signals. It is taken at the first sign of a migraine attack and works best when taken early, though it does not prevent migraines from occurring.

Moleküler Ağırlık

335,5000 g/mol

LogP

2,00

TPSA

73,60 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Cardiovascular Disease Migraine

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1

InChI

InChI=1S/C17H25N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-4,11-12,14,18-19H,5-10H2,1-2H3

Molecular Formula

C17H25N3O2S

HBD / HBA

2 / 4

Döndürülebilir Bağlar

5

Ağır Atomlar

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This medication is used to treat migraine headaches with or without aura by narrowing blood vessels in the brain and blocking pain signals. It is taken at the first sign of a migraine attack and works best when taken early, though it does not prevent migraines from occurring.

Yes, Naratriptan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1278. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4440. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Naratriptan PillFYI'da

Yapı

Hızlı Veriler

Formül: C17H25N3O2S

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.